June 26, 2019
The AAAAI with Pew Charitable Trusts and others advocates for passage of H.R. 3443, the bipartisan Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019. If enacted, H.R. 3443 would modernize the Food and Drug Administration’s (FDA) regulatory system, designed decades ago. Read more here.
January 17, 2018
The AAAAI supports current legislative efforts to update the processes by which over-the-counter (OTC) drugs are approved or changed to/from prescription drug status. The AAAAI is part of a joint effort including the Pew Charitable Trust, the American Academy of Pediatrics, the American Academy of Dermatology, the Society for Maternal and Fetal Medicine, and others in support of bills in the House and Senate to enable the Food and Drug Administration (FDA) to more quickly respond to safety data on currently available products and also to allow new products with sufficient safety data to make it to market more quickly.
Click here for a description of S.2315, the Over-the-Counter Drug Safety, Innovation and Reform Act. To read a letter regarding this legislation sent by the AAAAI and our partners in this effort to the House Energy and Commerce Subcommittee on Health, click here.